Loading…
Predicting peptide vaccine candidates against H1N1 influenza virus through theoretical approaches
Identification of potential epitopes that might activate the immune system has been facilitated by the employment of algorithms that use experimental data as templates. However, in order to prove the affinity and the map of interactions between the receptor (major histocompatibility complex, MHC, or...
Saved in:
Published in: | Immunologic research 2015-05, Vol.62 (1), p.3-15 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c415t-d0c20626f1fa721eeae39570338acb96b548072b6ce307cce4193bbfa2c885603 |
---|---|
cites | cdi_FETCH-LOGICAL-c415t-d0c20626f1fa721eeae39570338acb96b548072b6ce307cce4193bbfa2c885603 |
container_end_page | 15 |
container_issue | 1 |
container_start_page | 3 |
container_title | Immunologic research |
container_volume | 62 |
creator | Bello, Martiniano Campos-Rodriguez, Rafael Rojas-Hernandez, Saul Contis-Montes de Oca, Arturo Correa-Basurto, José |
description | Identification of potential epitopes that might activate the immune system has been facilitated by the employment of algorithms that use experimental data as templates. However, in order to prove the affinity and the map of interactions between the receptor (major histocompatibility complex, MHC, or T-cell receptor) and the potential epitope, further computational studies are required. Docking and molecular dynamics (MDs) simulations have been an effective source of generating structural information at molecular level in immunology. Herein, in order to provide a detailed understanding of the origins of epitope recognition and to select the best peptide candidate to develop an epitope-based vaccine, docking and MDs simulations in combination with MMGBSA free energy calculations and per-residue free energy decomposition were performed, taking as starting complexes those formed between four designed epitopes (P1–P4) from hemagglutinin (HA) of the H1N1 influenza virus and MHC-II anchored in POPC membrane. Our results revealed that the energetic contributions of individual amino acids within the pMHC-II complexes are mainly dictated by van der Waals interactions and the nonpolar part of solvation energy, whereas the electrostatic interactions corresponding to hydrogen bonds and salt bridges determine the binding specificity, being the most favorable interactions formed between p4 and MHC-II. Then, P1–P4 epitopes were synthesized and tested experimentally to compare theoretical and experimental results. Experimental results show that P4 elicited the highest strong humoral immune response to HA of the H1N1 and may induce antibodies that are cross-reactive to other influenza subtypes, suggesting that it could be a good candidate for the development of a peptide-based vaccine. |
doi_str_mv | 10.1007/s12026-015-8629-1 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1680188158</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3677800001</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-d0c20626f1fa721eeae39570338acb96b548072b6ce307cce4193bbfa2c885603</originalsourceid><addsrcrecordid>eNp1kM9rFTEQx4NY7LPtH-BFAl68bDuT3fzYo5RqhVI9KHgL2ezseyn7smuyW6h_vSmvShE8Dcx85jvDh7E3COcIoC8yChCqApSVUaKt8AXboJRtBVrKl2wDQupKaP3jmL3O-Q4AVdPUr9hx6aNS2GyY-5qoD34JcctnmpfQE7933odI3LvYh94tlLnbuhDzwq_xFnmIw7hS_OX4fUhr5ssuTet2VypNiZbg3cjdPKfJ-R3lU3Y0uDHT2VM9Yd8_Xn27vK5uvnz6fPnhpvINyqXqwQtQQg04OC2QyFHdSg11bZzvWtXJxoAWnfJUg_aeGmzrrhuc8MZIBfUJe3_ILYd_rpQXuw_Z0zi6SNOaLSoDaAxKU9B3_6B305pi-a5Quq01aqUKhQfKpynnRIOdU9i79GAR7KN_e_Bvi3_76N9i2Xn7lLx2e-r_bvwRXgBxAHIZxS2lZ6f_m_obm-GQiQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1679371766</pqid></control><display><type>article</type><title>Predicting peptide vaccine candidates against H1N1 influenza virus through theoretical approaches</title><source>Springer Link</source><creator>Bello, Martiniano ; Campos-Rodriguez, Rafael ; Rojas-Hernandez, Saul ; Contis-Montes de Oca, Arturo ; Correa-Basurto, José</creator><creatorcontrib>Bello, Martiniano ; Campos-Rodriguez, Rafael ; Rojas-Hernandez, Saul ; Contis-Montes de Oca, Arturo ; Correa-Basurto, José</creatorcontrib><description>Identification of potential epitopes that might activate the immune system has been facilitated by the employment of algorithms that use experimental data as templates. However, in order to prove the affinity and the map of interactions between the receptor (major histocompatibility complex, MHC, or T-cell receptor) and the potential epitope, further computational studies are required. Docking and molecular dynamics (MDs) simulations have been an effective source of generating structural information at molecular level in immunology. Herein, in order to provide a detailed understanding of the origins of epitope recognition and to select the best peptide candidate to develop an epitope-based vaccine, docking and MDs simulations in combination with MMGBSA free energy calculations and per-residue free energy decomposition were performed, taking as starting complexes those formed between four designed epitopes (P1–P4) from hemagglutinin (HA) of the H1N1 influenza virus and MHC-II anchored in POPC membrane. Our results revealed that the energetic contributions of individual amino acids within the pMHC-II complexes are mainly dictated by van der Waals interactions and the nonpolar part of solvation energy, whereas the electrostatic interactions corresponding to hydrogen bonds and salt bridges determine the binding specificity, being the most favorable interactions formed between p4 and MHC-II. Then, P1–P4 epitopes were synthesized and tested experimentally to compare theoretical and experimental results. Experimental results show that P4 elicited the highest strong humoral immune response to HA of the H1N1 and may induce antibodies that are cross-reactive to other influenza subtypes, suggesting that it could be a good candidate for the development of a peptide-based vaccine.</description><identifier>ISSN: 0257-277X</identifier><identifier>EISSN: 1559-0755</identifier><identifier>DOI: 10.1007/s12026-015-8629-1</identifier><identifier>PMID: 25716614</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Allergology ; Amino acids ; Animals ; Biomedical and Life Sciences ; Biomedicine ; Epitopes - administration & dosage ; Epitopes - chemistry ; Epitopes - immunology ; Hemagglutinin Glycoproteins, Influenza Virus - immunology ; Histocompatibility Antigens Class II - chemistry ; Histocompatibility Antigens Class II - immunology ; Immune system ; Immunoglobulin G - blood ; Immunology ; Influenza A Virus, H1N1 Subtype ; Influenza Vaccines - administration & dosage ; Internal Medicine ; Lipid Bilayers - chemistry ; Medicine/Public Health ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Peptides ; Peptides - administration & dosage ; Peptides - chemistry ; Peptides - immunology ; Phosphatidylcholines - chemistry ; Rabbits ; Swine flu ; Vaccines</subject><ispartof>Immunologic research, 2015-05, Vol.62 (1), p.3-15</ispartof><rights>Springer Science+Business Media New York 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-d0c20626f1fa721eeae39570338acb96b548072b6ce307cce4193bbfa2c885603</citedby><cites>FETCH-LOGICAL-c415t-d0c20626f1fa721eeae39570338acb96b548072b6ce307cce4193bbfa2c885603</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25716614$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bello, Martiniano</creatorcontrib><creatorcontrib>Campos-Rodriguez, Rafael</creatorcontrib><creatorcontrib>Rojas-Hernandez, Saul</creatorcontrib><creatorcontrib>Contis-Montes de Oca, Arturo</creatorcontrib><creatorcontrib>Correa-Basurto, José</creatorcontrib><title>Predicting peptide vaccine candidates against H1N1 influenza virus through theoretical approaches</title><title>Immunologic research</title><addtitle>Immunol Res</addtitle><addtitle>Immunol Res</addtitle><description>Identification of potential epitopes that might activate the immune system has been facilitated by the employment of algorithms that use experimental data as templates. However, in order to prove the affinity and the map of interactions between the receptor (major histocompatibility complex, MHC, or T-cell receptor) and the potential epitope, further computational studies are required. Docking and molecular dynamics (MDs) simulations have been an effective source of generating structural information at molecular level in immunology. Herein, in order to provide a detailed understanding of the origins of epitope recognition and to select the best peptide candidate to develop an epitope-based vaccine, docking and MDs simulations in combination with MMGBSA free energy calculations and per-residue free energy decomposition were performed, taking as starting complexes those formed between four designed epitopes (P1–P4) from hemagglutinin (HA) of the H1N1 influenza virus and MHC-II anchored in POPC membrane. Our results revealed that the energetic contributions of individual amino acids within the pMHC-II complexes are mainly dictated by van der Waals interactions and the nonpolar part of solvation energy, whereas the electrostatic interactions corresponding to hydrogen bonds and salt bridges determine the binding specificity, being the most favorable interactions formed between p4 and MHC-II. Then, P1–P4 epitopes were synthesized and tested experimentally to compare theoretical and experimental results. Experimental results show that P4 elicited the highest strong humoral immune response to HA of the H1N1 and may induce antibodies that are cross-reactive to other influenza subtypes, suggesting that it could be a good candidate for the development of a peptide-based vaccine.</description><subject>Allergology</subject><subject>Amino acids</subject><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Epitopes - administration & dosage</subject><subject>Epitopes - chemistry</subject><subject>Epitopes - immunology</subject><subject>Hemagglutinin Glycoproteins, Influenza Virus - immunology</subject><subject>Histocompatibility Antigens Class II - chemistry</subject><subject>Histocompatibility Antigens Class II - immunology</subject><subject>Immune system</subject><subject>Immunoglobulin G - blood</subject><subject>Immunology</subject><subject>Influenza A Virus, H1N1 Subtype</subject><subject>Influenza Vaccines - administration & dosage</subject><subject>Internal Medicine</subject><subject>Lipid Bilayers - chemistry</subject><subject>Medicine/Public Health</subject><subject>Molecular Docking Simulation</subject><subject>Molecular Dynamics Simulation</subject><subject>Peptides</subject><subject>Peptides - administration & dosage</subject><subject>Peptides - chemistry</subject><subject>Peptides - immunology</subject><subject>Phosphatidylcholines - chemistry</subject><subject>Rabbits</subject><subject>Swine flu</subject><subject>Vaccines</subject><issn>0257-277X</issn><issn>1559-0755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp1kM9rFTEQx4NY7LPtH-BFAl68bDuT3fzYo5RqhVI9KHgL2ezseyn7smuyW6h_vSmvShE8Dcx85jvDh7E3COcIoC8yChCqApSVUaKt8AXboJRtBVrKl2wDQupKaP3jmL3O-Q4AVdPUr9hx6aNS2GyY-5qoD34JcctnmpfQE7933odI3LvYh94tlLnbuhDzwq_xFnmIw7hS_OX4fUhr5ssuTet2VypNiZbg3cjdPKfJ-R3lU3Y0uDHT2VM9Yd8_Xn27vK5uvnz6fPnhpvINyqXqwQtQQg04OC2QyFHdSg11bZzvWtXJxoAWnfJUg_aeGmzrrhuc8MZIBfUJe3_ILYd_rpQXuw_Z0zi6SNOaLSoDaAxKU9B3_6B305pi-a5Quq01aqUKhQfKpynnRIOdU9i79GAR7KN_e_Bvi3_76N9i2Xn7lLx2e-r_bvwRXgBxAHIZxS2lZ6f_m_obm-GQiQ</recordid><startdate>20150501</startdate><enddate>20150501</enddate><creator>Bello, Martiniano</creator><creator>Campos-Rodriguez, Rafael</creator><creator>Rojas-Hernandez, Saul</creator><creator>Contis-Montes de Oca, Arturo</creator><creator>Correa-Basurto, José</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20150501</creationdate><title>Predicting peptide vaccine candidates against H1N1 influenza virus through theoretical approaches</title><author>Bello, Martiniano ; Campos-Rodriguez, Rafael ; Rojas-Hernandez, Saul ; Contis-Montes de Oca, Arturo ; Correa-Basurto, José</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-d0c20626f1fa721eeae39570338acb96b548072b6ce307cce4193bbfa2c885603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Allergology</topic><topic>Amino acids</topic><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Epitopes - administration & dosage</topic><topic>Epitopes - chemistry</topic><topic>Epitopes - immunology</topic><topic>Hemagglutinin Glycoproteins, Influenza Virus - immunology</topic><topic>Histocompatibility Antigens Class II - chemistry</topic><topic>Histocompatibility Antigens Class II - immunology</topic><topic>Immune system</topic><topic>Immunoglobulin G - blood</topic><topic>Immunology</topic><topic>Influenza A Virus, H1N1 Subtype</topic><topic>Influenza Vaccines - administration & dosage</topic><topic>Internal Medicine</topic><topic>Lipid Bilayers - chemistry</topic><topic>Medicine/Public Health</topic><topic>Molecular Docking Simulation</topic><topic>Molecular Dynamics Simulation</topic><topic>Peptides</topic><topic>Peptides - administration & dosage</topic><topic>Peptides - chemistry</topic><topic>Peptides - immunology</topic><topic>Phosphatidylcholines - chemistry</topic><topic>Rabbits</topic><topic>Swine flu</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bello, Martiniano</creatorcontrib><creatorcontrib>Campos-Rodriguez, Rafael</creatorcontrib><creatorcontrib>Rojas-Hernandez, Saul</creatorcontrib><creatorcontrib>Contis-Montes de Oca, Arturo</creatorcontrib><creatorcontrib>Correa-Basurto, José</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Immunologic research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bello, Martiniano</au><au>Campos-Rodriguez, Rafael</au><au>Rojas-Hernandez, Saul</au><au>Contis-Montes de Oca, Arturo</au><au>Correa-Basurto, José</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predicting peptide vaccine candidates against H1N1 influenza virus through theoretical approaches</atitle><jtitle>Immunologic research</jtitle><stitle>Immunol Res</stitle><addtitle>Immunol Res</addtitle><date>2015-05-01</date><risdate>2015</risdate><volume>62</volume><issue>1</issue><spage>3</spage><epage>15</epage><pages>3-15</pages><issn>0257-277X</issn><eissn>1559-0755</eissn><abstract>Identification of potential epitopes that might activate the immune system has been facilitated by the employment of algorithms that use experimental data as templates. However, in order to prove the affinity and the map of interactions between the receptor (major histocompatibility complex, MHC, or T-cell receptor) and the potential epitope, further computational studies are required. Docking and molecular dynamics (MDs) simulations have been an effective source of generating structural information at molecular level in immunology. Herein, in order to provide a detailed understanding of the origins of epitope recognition and to select the best peptide candidate to develop an epitope-based vaccine, docking and MDs simulations in combination with MMGBSA free energy calculations and per-residue free energy decomposition were performed, taking as starting complexes those formed between four designed epitopes (P1–P4) from hemagglutinin (HA) of the H1N1 influenza virus and MHC-II anchored in POPC membrane. Our results revealed that the energetic contributions of individual amino acids within the pMHC-II complexes are mainly dictated by van der Waals interactions and the nonpolar part of solvation energy, whereas the electrostatic interactions corresponding to hydrogen bonds and salt bridges determine the binding specificity, being the most favorable interactions formed between p4 and MHC-II. Then, P1–P4 epitopes were synthesized and tested experimentally to compare theoretical and experimental results. Experimental results show that P4 elicited the highest strong humoral immune response to HA of the H1N1 and may induce antibodies that are cross-reactive to other influenza subtypes, suggesting that it could be a good candidate for the development of a peptide-based vaccine.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>25716614</pmid><doi>10.1007/s12026-015-8629-1</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0257-277X |
ispartof | Immunologic research, 2015-05, Vol.62 (1), p.3-15 |
issn | 0257-277X 1559-0755 |
language | eng |
recordid | cdi_proquest_miscellaneous_1680188158 |
source | Springer Link |
subjects | Allergology Amino acids Animals Biomedical and Life Sciences Biomedicine Epitopes - administration & dosage Epitopes - chemistry Epitopes - immunology Hemagglutinin Glycoproteins, Influenza Virus - immunology Histocompatibility Antigens Class II - chemistry Histocompatibility Antigens Class II - immunology Immune system Immunoglobulin G - blood Immunology Influenza A Virus, H1N1 Subtype Influenza Vaccines - administration & dosage Internal Medicine Lipid Bilayers - chemistry Medicine/Public Health Molecular Docking Simulation Molecular Dynamics Simulation Peptides Peptides - administration & dosage Peptides - chemistry Peptides - immunology Phosphatidylcholines - chemistry Rabbits Swine flu Vaccines |
title | Predicting peptide vaccine candidates against H1N1 influenza virus through theoretical approaches |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T19%3A25%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predicting%20peptide%20vaccine%20candidates%20against%20H1N1%20influenza%20virus%20through%20theoretical%20approaches&rft.jtitle=Immunologic%20research&rft.au=Bello,%20Martiniano&rft.date=2015-05-01&rft.volume=62&rft.issue=1&rft.spage=3&rft.epage=15&rft.pages=3-15&rft.issn=0257-277X&rft.eissn=1559-0755&rft_id=info:doi/10.1007/s12026-015-8629-1&rft_dat=%3Cproquest_cross%3E3677800001%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-d0c20626f1fa721eeae39570338acb96b548072b6ce307cce4193bbfa2c885603%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1679371766&rft_id=info:pmid/25716614&rfr_iscdi=true |